Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Novo Nordisk A/S (NVO) had Return on Equity of 20.96% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$11.02B |
|
$4.10B |
|
$1.82B |
|
$9.20B |
|
$5.54B |
|
$5.47B |
|
$-248.05M |
|
$5.23B |
|
$5.23B |
|
$4.10B |
|
$4.10B |
|
$4.10B |
|
$4.10B |
|
$5.47B |
|
$6.01B |
|
4.44B |
|
4.45B |
|
$0.92 |
|
$0.92 |
|
| Balance Sheet Financials | |
$24.61B |
|
$24.32B |
|
$44.41B |
|
$69.02B |
|
$33.32B |
|
$13.59B |
|
$16.16B |
|
$49.47B |
|
$19.55B |
|
$4.11B |
|
$19.55B |
|
-- |
|
| Cash Flow Statement Financials | |
$3.47B |
|
$-941.56M |
|
$769.14M |
|
$2.21B |
|
$5.49B |
|
$3.29B |
|
-- |
|
$-2.12B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
0.41 |
|
0.86 |
|
83.49% |
|
49.68% |
|
49.68% |
|
-- |
|
47.43% |
|
37.18% |
|
$1.58B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.30 |
|
0.90 |
|
99.54 |
|
|
Return on Equity |
20.96% |
99.56% |
|
5.94% |
|
12.36% |
|
-- |
|
$0.35 |
|
$0.78 |
|